MiMedx Group (MDXG) Guides FY16 Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Canaccord Genuity Raises Price target on MiMedx Group (MDXG) Following 2016 Guidance Release
December 18, 2015 8:48 AM ESTCanaccord Genuity reiterated a Buy rating on MiMedx Group (NASDAQ: MDXG), and raised the price target to $12.00 (from $10.00), following the company's release of 2016 guidance. Revenue guidance of $245M-255M equates to 30-38% growth. MiMedx noted that growth in wound care would continue... More



